YB

Yogesh Bajpai

Director Director DIN 06905883
DIN 06905883 First appointment Sep 2014 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2014
Shareholding value Locked Premium profile

About Yogesh Bajpai

Yogesh Bajpai has 11 years in corporate governance. Formerly with 1 company, such as Bioclinical Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06905883
Primary Designation Director
First Appointment 03 Sep 2014
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 03 Sep 2014 2014 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bioclinical Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yogesh Bajpai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Bajpai

Yogesh Bajpai has 11 years in corporate governance. Formerly with 1 company, such as Bioclinical Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Yogesh Bajpai is associated with 0 companies as a director.

Yogesh Bajpai has expertise in General Business.

Yogesh Bajpai has 11 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available